Levodopa‐Carbidopa Intestinal Gel Reduces Dyskinesia in Parkinson's Disease in a Randomized Trial

BACKGROUND: There are limited data regarding the effectiveness of levodopa‐carbidopa intestinal gel (LCIG) for dyskinesia. OBJECTIVE: Compare the effectiveness of LCIG versus oral optimized medical treatment (OMT) for dyskinesia in patients with advanced Parkinson's disease (PD) using the Unifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Freire‐Alvarez, Eric, Kurča, Egon, Lopez Manzanares, Lydia, Pekkonen, Eero, Spanaki, Cleanthe, Vanni, Paola, Liu, Yang, Sánchez‐Soliño, Olga, Barbato, Luigi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Regular Issue Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292774/
https://www.ncbi.nlm.nih.gov/pubmed/34236101
http://dx.doi.org/10.1002/mds.28703

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292774/
https://www.ncbi.nlm.nih.gov/pubmed/34236101
http://dx.doi.org/10.1002/mds.28703

Ejemplares similares